Clinical trial
The Analysis of Blood Stasis Syndromeand of Coronary Heart Disease Related MicroRNA Genomics and Target Gene Regulatory Networks
NCT01615003 is registered in ClinicalTrials.gov with Guang'anmen Hospital of China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Analysis of Blood Stasis Syndromeand of Coronary Heart Disease Related MicroRNA Genomics and Target Gene Regulatory Networks
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 31, 2012
- Completion date
- December 31, 2014
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood stasis syndrome, coronary heart disease, unstable angina